obtained as E. coli lysates from Dr . R. Kastelein at DNAX and as a purified protein from Amgen Biologicals (Thousand Oaks, CA). Human rIL-1 a was obtained from Dr . Zurawski at DNAX in the form of E. coli lysates. It was purified by SDS-PAGE and the IL-1 was eluted from its migration area in the gel by reverse electrophoresis . A commercial preparation of a low-molecular-weight B cell growth factor (BCGF) purified from the culture supernatants of PHA-stimulated PBL was obtained from Cellular Products Inc. (Buffalo, NY) and is referred to in the text as commercial BCGF (cBCGF). This preparation was free from IL-2 and IFN-y activity, as determined by measurement of the [sH]-TdR uptake by the IL-2-dependent mouse T cell line CTLL-2 and an ELISA assay, respectively .
B Cell Preparations and Cultures. B cells were isolated either from tonsils or from blood cytapheresis residues . Mononuclear cells were separated by the standard Ficoll/Hypaque gradient method . Tonsil B cells were obtained by twice rosetting with amino ethyl isothiouronium bromide (AET)-treated SRBC, while blood B cells were submitted to a single rosetting with AET-treated SRBC followed by complement-mediated lysis of the remaining T cells with the use of anti-T3 (CD3), -T4 (CD4), -T8 (CD8), -TI 1 (CD2) mAbs . Depletion of blood monocytes, null cells and large granular lymphocytes was achieved by L-leucine methyl ester treatment according to the method described by Thiele et al . (4) . The B cell-enriched populations obtained were typically >95% surface Igpositive, >95% B 1 antigen (CD20)-positive . <1% of the cells were positively stained by the T cell markers Leu-1, OKT4, OKT8, and OKT1 I or by the monocyte markers: Leu-M3, MOI (CD11), M02 (CD14) . <1% of the cells reacted with the NK cell markers: Leu-7 and Leu-11 (CD 16).
Purified B cells were cultured at 10 6 cells/ml in Iscove's medium enriched with 50 gg/ml human transferrin, 5 tag/ml bovine insulin, 0.5% BSA, oleic, linoleic, and palmitic acids (all from Sigma Chemical Co ., St . Louis, MO) as described by Yssei et al . (5) . 2% FCS was added to the medium .
Analysis with a FACS . Fluorescence analysis was performed with a FACS 440 (Becton Dickinson & Co ., Sunnyvale, CA) equipped with a 5 W argon laser running at 488 nm, 0.5 W . Fluorescence parameters were collected using a built in logarithmic amplifier after gating on the combination of forward light scatter (FLS) and perpendicular light scatter (PLS), which was used to discriminate viable from nonviable cells.
Cell Staining. 4 x 105 cells were incubated with 50 Al of the appropriately diluted mAb in 0 .2-ml microtiter plate wells. After two washes with PBS containing 1% BSA, 0.01 % sodium azide, cells were incubated with fluoresceinated F(ab')2 fragments of goat anti-mouse Ig (Grub) for 30 min at 4°C. After three washes with PBS/BSA/azide, the cells were analyzed with the FACS .
Simultaneous Measurement of RNA Content and Surface Antigen Expression . The procedure used was adapted from Shapiro (6) . 106 cells/mI in PBS/1 % BSA/0.01 % sodium azide were incubated at 37°C for 45 min with 5 AM pyronin Y (PY; Aldrich Chemical Co ., Milwaukee, WI). After centrifugation the cells were resuspended in cold PBS/BSA containing 4,uM PY (PBS/PY) and the mAb was added at the appropriate dilution . After an incubation of 30 min at 4°C the cells were washed twice in cold PBS/PY then resuspended in PBS/PY containing the fluorescent-conjugated goat anti-mouse Ig . After 30 min at VC, C, the cells were washed twice with cold PBS/PY and resuspended in PBS/PY . Analyses were performed within 15 min after staining. 15,000 cells were recorded . The green fluorescence (530 nm) specific for antibody staining is recorded with logarithmic amplification; the red fluorescence (>600 nm) specific for RNA staining is recorded with linear amplification . To determine the concentration that induces optimal FceR L/CD23 induction, experiments were carried out with highly purified rIL-4 obtained from transfected COS-7 supernatants. Data in Fig. 2 show that the maximum expression of FceR L/CD23 on anti-IgM-activated B cells is obtained with 700 pg/ml IL-4 . The half-maximal induction of FceR L/CD23 is obtained with -176 pg/ml IL-4 .
It has been shown that activated B lymphocytes can proliferate in response to The induction of FcER L/CD23 on B cells seems to be specific for IL-4 . rIL-2, rIFN-y, rIL-1a, semipurified low-molecular-weight BCGF or the supernatant of EBV lymphoblastoid cell lines (LCL) containing BCGF activity but no IL-4 (as determined by the absence of IL-4 mRNA in the cell line) were unable to induce FceRL/CD23 expression on normal B cells. Human rIL-4 has a FceR L/CD23-inducing activity comparable to the lymphokine purified from PHA-activated mononuclear cells supernatants studied by Suemura et al . (16) . None of the tested lymphokines acted in concert or in synergy with IL-4, but interestingly, IFN-y strongly inhibited the FceR L/CD23-inducing effect of IL-4 . Strong inhibitory effects were observed at IFN-y concentrations of 1 IU/ml. Although considerable blocking effects were obtained after 24 h of incubation with IL-4, the effect was most pronounced after 48 h. The mechanism by which IFN-y blocks IL-4-induced FceR L/CD23 expression is presently under investigation. This inhibitory effect of IFN-y is in line with the described antagonizing effects of marine IFN-y on the proliferation of anti-IgM-activated B cells (17) , the increase of class lI MHC antigens on B cells, the increase in cell size (18, 19) , and IgE and IgGI production by LPS blasts (20) induced by IL-4 . By contrast, the IL-4-induced proliferation of preactivated human B cells was stimulated by IFN-y (Defrance, T., B. Vanbervliet, J. P. Aubrey, et al ., manuscript submitted for publication) .
At the present time the biological significance of the IL-4-induced FceR L/CD23 expression is unclear. The recent suggestion by Gordon et al . (21, 22 ) that the CD23 antigen may be the receptor for the low-molecular-weight BCGF (7) is worth considering, since it is in line with our data that indicate that IL-4 synergizes with the low-molecular-weight BCGF in inducing the proliferation of preactivated B cells (Defrance, T., B. Vanbervliet, J. P. Aubrey, et al ., manuscript submitted for publication). The demonstration that IL-4 is able to induce (a) FceRL on human B lymphocytes, (b) the proliferation of marine mast cells, and (c) IgE production by murine LPS blasts, demonstrates that IL-4 plays a major role in the IgE system at both the regulatory and the effector levels since it has been suggested that FceR L+ B cells play a major role in the regulation of IgE secretion (23) . This hypothesis is confirmed by the recent finding that the in vivo injection of a mAb specific for mouse IL-4 (24) into Nippostrongylus brasiliensis-infected mice abrogates the induction of IgE production mediated by this treatment (25) . The biological functions of FceR L/CD23 on B lymphocytes and the biological significance of its modulation by IL-4 and IFN-y remain to be determined . 
